🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of lisocab...
Status
Recruiting
Location
University Of Colorado
Start Date
2025-11-06
Trial ID
NCT07015242
This is a 12-month phase 2, prospective, open label study to evaluate the e...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00446251
Treatments Being Tested
This is a prospective, multicenter phase II trial designed to determine eff...
Status
Completed
Location
SC Ematologia - AO SS. Antonio e Biagio e C. Arrigo
Start Date
2011-01
Trial ID
NCT01929265
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Status
Completed
Location
Naval Medical Center - San Diego
Start Date
2002-05
Trial ID
NCT00039130
A randomized trial of long-term dosage of rituximab in multiple sclerosis...
Status
Unknown
Location
Anders Svenningsson
Start Date
2018-07-04
Trial ID
NCT03979456
Treatments Being Tested
Chronic inflammatory demyelinating polyneuropathy is disease believed to be...
Status
Completed
Location
Northwestern University, Feinberg School of Medicine
Start Date
2005-02-21
Trial ID
NCT00278629
Treatments Being Tested
The purpose of this study is to evaluate biosimilarity between test product...
Status
Completed
Location
Clinical Centre Banja Luka Location Paprikovac
Start Date
2013-05
Trial ID
NCT02468791
Treatments Being Tested
This is a retrospective observational study of the therapeutic mechanism an...
Status
Unknown
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2023-06-30
Trial ID
NCT05923879
Treatments Being Tested
The study hypothesis is that a "reinforced" pneumococcal combined vaccine s...
Status
Completed
Location
Pôle de Médecine Interne, Centre de référence " Maladies systémiques et autoimmunes rares, en particulier Vascularites nécrosantes et Sclérodermies systémiques " Hôpital Cochin, Assistance Publique-Hôpitaux de Paris
Start Date
2018-02-05
Trial ID
NCT03069703
This study is designed to evaluate the efficacy and safety of the current t...
Status
Unknown
Location
The Second Xiangya Hospital, Central South University
Start Date
2018-12-01
Trial ID
NCT03791827